|
|
||||||||





* Department of Medicine and
Division of Bioinformatics, University of Washington, Seattle, WA 98105; and
Department of Internal Medicine, Centre Hospitalier Universitaire La Pitié-Salpêtrière, Paris, France
The t(14;18) chromosomal translocation, which joins the Bcl-2 proto-oncogene to an Ig JH gene, has increased prevalence in patients chronically infected with hepatitis C virus (HCV). We now establish a link between the molecular structure and clinical occurrence of HCV-associated t(14;18). A t(14;18) was detected by PCR in leukocytes from 22 of 46 HCV-infected patients (48%) and 11 of 54 healthy controls (20%) (p = 0.0053). Nucleotide sequence analysis of the Bcl-2/JH joins found a JH6 gene in 18 of 22 (82%) t(14;18) from HCV+ patients, and 3 of 8 (38%) from controls (p = 0.031). The t(14;18) rarely contained JH gene mutations, or an intervening region sequence suggestive of D gene rearrangement or templated nucleotide insertion. Analysis of published t(14;18) nucleotide sequences established that the JH6 prevalence in t(14;18) from normal/nonneoplastic controls (48%) was significantly lower than in t(14;18) from our HCV+ patients (p = 0.004) or from non-Hodgkins lymphomas (66%, p = 0.003). We conclude that the increased prevalence of t(14;18) in HCV+ patients occurs with a strong bias for Bcl-2/JH6 joins. In this regard, HCV-associated t(14;18) more closely resemble t(14;18) in lymphomas than t(14;18) from normal subjects.
This article has been cited by other articles:
![]() |
Y. Cao, Y. Zhang, S. Wang, and W. Zou Detection of the hepatitis C virus antigen in kidney tissue from infected patients with various glomerulonephritis Nephrol. Dial. Transplant., September 1, 2009; 24(9): 2745 - 2751. [Abstract] [Full Text] [PDF] |
||||
![]() |
D-A Landau, M Rosenzwajg, D Saadoun, D Klatzmann, and P Cacoub The B lymphocyte stimulator receptor-ligand system in hepatitis C virus-induced B cell clonal disorders Ann Rheum Dis, March 1, 2009; 68(3): 337 - 344. [Abstract] [Full Text] [PDF] |
||||
![]() |
D S Viswanatha and A Dogan Hepatitis C virus and lymphoma J. Clin. Pathol., December 1, 2007; 60(12): 1378 - 1383. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Sene, N. Limal, P. Ghillani-Dalbin, D. Saadoun, J.-C. Piette, and P. Cacoub Hepatitis C virus-associated B-cell proliferation--the role of serum B lymphocyte stimulator (BLyS/BAFF) Rheumatology, January 1, 2007; 46(1): 65 - 69. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Baccarelli, C. Hirt, A. C. Pesatori, D. Consonni, D. G. Patterson Jr, P. A. Bertazzi, G. Dolken, and M. T. Landi t(14;18) translocations in lymphocytes of healthy dioxin-exposed individuals from Seveso, Italy Carcinogenesis, October 1, 2006; 27(10): 2001 - 2007. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Libra, A. Gloghini, P. M. Navolanic, A. L. Zignego, V. De Re, A. Carbone, and E. H. Sasso JH6 Gene Usage among HCV-Associated MALT Lymphomas Harboring t(14;18) Translocation J. Immunol., April 1, 2005; 174(7): 3839 - 3839. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |